請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58933完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 繆希椿(Shi-Chuen Miaw) | |
| dc.contributor.author | Hsiao-Wei Tsao | en |
| dc.contributor.author | 曹孝瑋 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:39:35Z | - |
| dc.date.available | 2014-02-25 | |
| dc.date.copyright | 2014-02-25 | |
| dc.date.issued | 2013 | |
| dc.date.submitted | 2013-10-01 | |
| dc.identifier.citation | Arman, M., Aguilera-Montilla, N., Mas, V., Puig-Kroger, A., Pignatelli, M., Guigo, R., Corbi, A.L., and Lozano, F. (2009). The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells. Mol Immunol 46, 2226-2235.
Avots, A., Hoffmeyer, A., Flory, E., Cimanis, A., Rapp, U.R., and Serfling, E. (1997). GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction. Mol Cell Biol 17, 4381-4389. Barton, K., Muthusamy, N., Fischer, C., Ting, C.N., Walunas, T.L., Lanier, L.L., and Leiden, J.M. (1998). The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9, 555-563. Bassuk, A.G., Anandappa, R.T., and Leiden, J.M. (1997). Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol 71, 3563-3573. Behrens, P., Mathiak, M., Mangold, E., Kirdorf, S., Wellmann, A., Fogt, F., Rothe, M., Florin, A., and Wernert, N. (2003). Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107, 183-188. Behrens, P., Rothe, M., Florin, A., Wellmann, A., and Wernert, N. (2001a). Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med 8, 149-154. Behrens, P., Rothe, M., Wellmann, A., Krischler, J., and Wernert, N. (2001b). The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194, 43-50. Bories, J.C., Willerford, D.M., Grevin, D., Davidson, L., Camus, A., Martin, P., Stehelin, D., and Alt, F.W. (1995). Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377, 635-638. Chen, C., Rowell, E.A., Thomas, R.M., Hancock, W.W., and Wells, A.D. (2006). Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 281, 36828-36834. Clements, J.L., John, S.A., and Garrett-Sinha, L.A. (2006). Impaired generation of CD8+ thymocytes in Ets-1-deficient mice. J Immunol 177, 905-912. Collins, S., Wolfraim, L.A., Drake, C.G., Horton, M.R., and Powell, J.D. (2006). Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription. J Immunol 177, 8301-8305. Crabtree, G.R., and Schreiber, S.L. (2009). SnapShot: Ca2+-calcineurin-NFAT signaling. Cell 138, 210, 210 e211. Cruz-Guilloty, F., Pipkin, M.E., Djuretic, I.M., Levanon, D., Lotem, J., Lichtenheld, M.G., Groner, Y., and Rao, A. (2009). Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 206, 51-59. Djuretic, I.M., Levanon, D., Negreanu, V., Groner, Y., Rao, A., and Ansel, K.M. (2007). Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 8, 145-153. Doi, T.S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y. (1997). NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med 185, 953-961. Ghysdael, J., Gegonne, A., Pognonec, P., Dernis, D., Leprince, D., and Stehelin, D. (1986). Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sci U S A 83, 1714-1718. Green, D.R., Droin, N., and Pinkoski, M. (2003). Activation-induced cell death in T cells. Immunol Rev 193, 70-81. Grenningloh, R., Kang, B.Y., and Ho, I.C. (2005). Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 201, 615-626. Grenningloh, R., Tai, T.S., Frahm, N., Hongo, T.C., Chicoine, A.T., Brander, C., Kaufmann, D.E., and Ho, I.C. (2011). Ets-1 maintains IL-7 receptor expression in peripheral T cells. J Immunol 186, 969-976. Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., Xu, J.H., Cai, Z.M., Huang, W., Zhao, G.P., et al. (2009). Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41, 1234-1237. Hart, A.H., Reventar, R., and Bernstein, A. (2000). Genetic analysis of ETS genes in C. elegans. Oncogene 19, 6400-6408. Hogan, P.G., Chen, L., Nardone, J., and Rao, A. (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17, 2205-2232. Hollenhorst, P.C., Chandler, K.J., Poulsen, R.L., Johnson, W.E., Speck, N.A., and Graves, B.J. (2009). DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet 5, e1000778. Hsu, T., and Schulz, R.A. (2000). Sequence and functional properties of Ets genes in the model organism Drosophila. Oncogene 19, 6409-6416. Intlekofer, A.M., Takemoto, N., Wherry, E.J., Longworth, S.A., Northrup, J.T., Palanivel, V.R., Mullen, A.C., Gasink, C.R., Kaech, S.M., Miller, J.D., et al. (2005). Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6, 1236-1244. Jain, J., McCaffrey, P.G., Miner, Z., Kerppola, T.K., Lambert, J.N., Verdine, G.L., Curran, T., and Rao, A. (1993). The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365, 352-355. Jain, J., Valge-Archer, V.E., and Rao, A. (1992). Analysis of the AP-1 sites in the IL-2 promoter. J Immunol 148, 1240-1250. Jayaraman, T., Ondriasova, E., Ondrias, K., Harnick, D.J., and Marks, A.R. (1995). The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci U S A 92, 6007-6011. Kallies, A., Hawkins, E.D., Belz, G.T., Metcalf, D., Hommel, M., Corcoran, L.M., Hodgkin, P.D., and Nutt, S.L. (2006). Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 7, 466-474. Kamimura, D., and Bevan, M.J. (2007). Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med 204, 1803-1812. Ke, Y., Ma, H., and Kapp, J.A. (1998). Antigen is required for the activation of effector activities, whereas interleukin 2 Is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes. J Exp Med 187, 49-57. Kingsley, D.M., Jenkins, N.A., and Copeland, N.G. (1989). A molecular genetic linkage map of mouse chromosome 9 with regional localizations for the Gsta, T3g, Ets-1 and Ldlr loci. Genetics 123, 165-172. Kola, I., Brookes, S., Green, A.R., Garber, R., Tymms, M., Papas, T.S., and Seth, A. (1993). The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci U S A 90, 7588-7592. Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. (1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9, 1965-1977. Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007). Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381. Lee, C.G., Kwon, H.K., Sahoo, A., Hwang, W., So, J.S., Hwang, J.S., Chae, C.S., Kim, G.C., Kim, J.E., So, H.S., et al. (2012). Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells. J Immunol 188, 2244-2253. Li, Y., Sun, L.D., Lu, W.S., Hu, W.L., Gao, J.P., Cheng, Y.L., Yu, Z.Y., Yao, S., He, C.F., Liu, J.L., et al. (2010). Expression analysis of ETS1 gene in peripheral blood mononuclear cells with systemic lupus erythematosus by real-time reverse transcription PCR. Chin Med J (Engl) 123, 2287-2288. Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H., and Lenardo, M.J. (2011). The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol 12, 1063-1070. Lulli, V., Romania, P., Morsilli, O., Gabbianelli, M., Pagliuca, A., Mazzeo, S., Testa, U., Peschle, C., and Marziali, G. (2006). Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ 13, 1064-1074. Macian, F., Garcia-Rodriguez, C., and Rao, A. (2000). Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19, 4783-4795. Mackereth, C.D., Scharpf, M., Gentile, L.N., MacIntosh, S.E., Slupsky, C.M., and McIntosh, L.P. (2004). Diversity in structure and function of the Ets family PNT domains. J Mol Biol 342, 1249-1264. Malek, T.R., and Bayer, A.L. (2004). Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4, 665-674. Martins, G.A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Magnusdottir, E., and Calame, K. (2006). Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7, 457-465. Moisan, J., Grenningloh, R., Bettelli, E., Oukka, M., and Ho, I.C. (2007). Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 204, 2825-2835. Morgan, D.A., Ruscetti, F.W., and Gallo, R. (1976). Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007-1008. Muller, M.R., and Rao, A. (2010). NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10, 645-656. Nagaleekar, V.K., Diehl, S.A., Juncadella, I., Charland, C., Muthusamy, N., Eaton, S., Haynes, L., Garrett-Sinha, L.A., Anguita, J., and Rincon, M. (2008). IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program. J Immunol 181, 8315-8322. Naoe, Y., Setoguchi, R., Akiyama, K., Muroi, S., Kuroda, M., Hatam, F., Littman, D.R., and Taniuchi, I. (2007). Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J Exp Med 204, 1749-1755. Nazneen, A., Razzaque, M.S., Liu, D., and Taguchi, T. (2002). Possible role of Ets-1 and MMP-1 in matrix remodeling in experimental cisplatin nephropathy. Med Electron Microsc 35, 242-247. Nelson, B.H. (2004). IL-2, regulatory T cells, and tolerance. J Immunol 172, 3983-3988. Nunn, M.F., Seeburg, P.H., Moscovici, C., and Duesberg, P.H. (1983). Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306, 391-395. Obika, S., Reddy, S.Y., and Bruice, T.C. (2003). Sequence specific DNA binding of Ets-1 transcription factor: molecular dynamics study on the Ets domain--DNA complexes. J Mol Biol 331, 345-359. Oda, N., Abe, M., and Sato, Y. (1999). ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 178, 121-132. Ohl, K., and Tenbrock, K. (2011). Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol 2011, 432595. Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., Miyachi, Y., Tsukada, T., and Sakaguchi, S. (2007). Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685-689. Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S., Zediak, V.P., Banica, M., DiCioccio, C.B., Gross, D.A., Mao, C.A., et al. (2003). Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043. Peng, S.L., Gerth, A.J., Ranger, A.M., and Glimcher, L.H. (2001). NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14, 13-20. Pfeuffer, I., Klein-Hessling, S., Heinfling, A., Chuvpilo, S., Escher, C., Brabletz, T., Hentsch, B., Schwarzenbach, H., Matthias, P., and Serfling, E. (1994). Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol 153, 5572-5585. Rabault, B., and Ghysdael, J. (1994). Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J Biol Chem 269, 28143-28151. Rao, A., Luo, C., and Hogan, P.G. (1997). Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15, 707-747. Romano-Spica, V., Georgiou, P., Suzuki, H., Papas, T.S., and Bhat, N.K. (1995). Role of ETS1 in IL-2 gene expression. J Immunol 154, 2724-2732. Rooney, J.W., Sun, Y.L., Glimcher, L.H., and Hoey, T. (1995). Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 15, 6299-6310. Safford, M., Collins, S., Lutz, M.A., Allen, A., Huang, C.T., Kowalski, J., Blackford, A., Horton, M.R., Drake, C., Schwartz, R.H., et al. (2005). Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6, 472-480. Sahin, A., Velten, M., Pietsch, T., Knuefermann, P., Okuducu, A.F., Hahne, J.C., and Wernert, N. (2005). Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. Int J Mol Med 15, 771-776. Sato, T., Ohno, S., Hayashi, T., Sato, C., Kohu, K., Satake, M., and Habu, S. (2005). Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22, 317-328. Savage, P.D., Hanson, C.A., and Kersey, J.H. (1987). Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23. Blood 70, 327-329. Sementchenko, V.I., and Watson, D.K. (2000). Ets target genes: past, present and future. Oncogene 19, 6533-6548. Setoguchi, R., Tachibana, M., Naoe, Y., Muroi, S., Akiyama, K., Tezuka, C., Okuda, T., and Taniuchi, I. (2008). Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822-825. Sharma, S., Findlay, G.M., Bandukwala, H.S., Oberdoerffer, S., Baust, B., Li, Z., Schmidt, V., Hogan, P.G., Sacks, D.B., and Rao, A. (2011). Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A 108, 11381-11386. Shibuya, H., and Taniguchi, T. (1989). Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene. Nucleic Acids Res 17, 9173-9184. Skalicky, J.J., Donaldson, L.W., Petersen, J.M., Graves, B.J., and McIntosh, L.P. (1996). Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1. Protein Sci 5, 296-309. Teruyama, K., Abe, M., Nakano, T., Iwasaka-Yagi, C., Takahashi, S., Yamada, S., and Sato, Y. (2001). Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J Cell Physiol 188, 243-252. Thomas, R.M., Chunder, N., Chen, C., Umetsu, S.E., Winandy, S., and Wells, A.D. (2007). Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol 179, 7305-7315. Ullman, K.S., Flanagan, W.M., Edwards, C.A., and Crabtree, G.R. (1991). Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254, 558-562. Walunas, T.L., Wang, B., Wang, C.R., and Leiden, J.M. (2000). Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol 164, 2857-2860. Wang, D., John, S.A., Clements, J.L., Percy, D.H., Barton, K.P., and Garrett-Sinha, L.A. (2005). Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 17, 1179-1191. Watson, D.K., McWilliams-Smith, M.J., Kozak, C., Reeves, R., Gearhart, J., Nunn, M.F., Nash, W., Fowle, J.R., 3rd, Duesberg, P., Papas, T.S., et al. (1986). Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans. Proc Natl Acad Sci U S A 83, 1792-1796. Willingham, A.T., Orth, A.P., Batalov, S., Peters, E.C., Wen, B.G., Aza-Blanc, P., Hogenesch, J.B., and Schultz, P.G. (2005). A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309, 1570-1573. Xu, F.L., Li, Y.L., Wang, Z.D., and Feng, Y.J. (2003). [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25, 396-400. Yang, L., Cohn, L., Zhang, D.H., Homer, R., Ray, A., and Ray, P. (1998). Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 188, 1739-1750. Yang, W., Shen, N., Ye, D.Q., Liu, Q., Zhang, Y., Qian, X.X., Hirankarn, N., Ying, D., Pan, H.F., Mok, C.C., et al. (2010). Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6, e1000841. Zamisch, M., Tian, L., Grenningloh, R., Xiong, Y., Wildt, K.F., Ehlers, M., Ho, I.C., and Bosselut, R. (2009). The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus. J Exp Med 206, 2685-2699. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58933 | - |
| dc.description.abstract | E26轉型特異性序列1(Ets-1)是ETS轉錄因子家族蛋白之原型，也是第一個被發現的ETS家族成員，其對於小鼠體內輔助型T細胞(Th cells)的介白素二(Interleukin-2, IL-2)表現非常重要，然而目前對於Ets-1如何促進介白素二的表現，其機制仍然不明。
我們的研究顯示，Ets-1不僅對小鼠的介白素二表現重要，它也是人類介白素二重要的調控因子。雖然Ets-1可負調控一已知的介白素二抑制者Blimp-1，但在Ets-1基因剔除的輔助型T細胞中再剔除Blimp-1並無法讓介白素二的生成恢復正常。 另一方面，Ets-1可以和NFAT蛋白產生交互作用，除了促進NFAT蛋白的功能之外，也是NFAT聚集並活化至介白素二之啟動子所必須。除此之外，在未活化的輔助型T細胞中，Ets-1同時分布於細胞核和細胞中，當受到鈣離子的訊號刺激之後，核中的Ets-1會快速的離開細胞核並和細胞質中的NFAT蛋白競爭與NRON 複合體的結合，讓NFAT蛋白離開NRON 複合體。這個Ets-1在細胞受到刺激後從細胞核進入細胞質的過程是發生在NFAT蛋白進入核之前，所以當細胞缺少Ets-1時，NFAT蛋白進入核的能力就會受到影響，但其被去磷酸化的能力則沒有變化。 因此，我們認為Ets-1調控介白素二的主要機制乃是透過控制NFAT蛋白的活性而達成的。這篇論文不只增進了我們對於介白素二轉錄機制的了解，另一方面更指出了Ets-1控制下游基因的特殊機制。 | zh_TW |
| dc.description.abstract | Ets-1, the prototype of the ETS family of transcription factors, is critical for the expression of IL-2 in murine and human T cells. Although IL-2 is a well characterized cytokine, how Ets-1 regulates the expression of IL-2 remains unclear. Here we show that Ets-1 is also essential for optimal production of IL-2 by murine CD8+ T cells and primary human T helper (Th) cells. We also observed an elevated Blimp-1 expression in Ets-1 KO T cells. Although Blimp-1 plays as a suppressor for IL-2, our data indicated that Blimp-1 is not responsible for the impaired IL-2 production in Ets-1 KO cells. The defects we observed in Ets-1-deficient cells cannot be rescued by Blimp-1 deficiency in Ets-1 KO cells. Instead, Ets-1 physically and functionally interacts with the nuclear factor of activated T-cells (NFAT) through multiple domains and is required for the recruitment of NFAT to the IL-2 promoter. In resting Th cells, Ets-1 is located both in nucleus and cytoplasm. When receiving calcium dependent signals from T cell receptors (TCR), nuclear Ets-1 starts to exit the nucleus and competes with NFAT proteins for binding to protein components of NRON (non-coding RNA repressor of NFAT) complex. NRON complex serves as a cytoplasmic trap for phosphorylated NFAT proteins in cytoplasm and this competition results in the release of NFAT from the complex. Ets-1 deficiency results in impaired nuclear entry, but not dephosphorylation, of NFAT proteins. We also found that the nuclear resident Ets-1 can interact with NFAT proteins to facilitate the transcription activity of NFAT in nucleus. Thus, Ets-1 promotes the expression of IL-2 by modulating the activity of NFAT. To the best of our knowledge, Ets-1 is the first transcription factor that is known to interact with NRON complex and facilitate nuclear entry of NFAT proteins. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:39:35Z (GMT). No. of bitstreams: 1 ntu-102-D95449004-1.pdf: 4466284 bytes, checksum: d2fbfcbd0b6e9d476986d0bf3d1419e8 (MD5) Previous issue date: 2013 | en |
| dc.description.tableofcontents | 中文摘要 7
ABSTRACT 8 CHARPTER I. Introduction 10 1.E26 transformation-specific sequence (Ets) family genes 10 2.Protein structure of Ets-1 10 3.Biological roles of Ets-1 13 4.Ets-1 and autoimmune diseases 14 5.Role of IL-2 in immune system 16 6.Transcriptional regulation of IL-2 16 7.Role of Ets-1 in the regulation of IL-2 18 8.NFAT proteins and NRON complex 19 9.Summary 21 10.Specific aims 22 CHARPTER II. Materials and methods 23 1.Materials 23 1-1 Buffers 23 1-2 Antibodies 28 1-3 Primers 29 2.Experimental procedures 31 2-1 Mice 31 2-2 Purification and differentiation of Th cells 31 2-3 Preparation of cytoplasmic and nuclear extract of Th cells 32 2-4 Luciferase assay 32 2-5 Co-immunoprecipitation 32 2-6 Intracellular cytokine staining 33 2-7 Western blot analysis 34 2-8 Real-time PCR 34 2-9 Chromatin immunoprecipitation (ChIP) 35 2-10 siRNA 36 2-11 Size-exclusion chromatography (Gel-filtration assay) 36 2-12 Concentration of Lentiviral/Retroviral Supernatants by Precipitation Using polyethylene glycol (PEG) 37 2-13 Spin Infection 37 CHARPTER III. Regulation of IL-2 by Ets-1 38 Results 38 1.Kinetics of Ets-1 and IL-2 expression in T cells 38 2.Ets-1 is required for IL-2 production in mouse CD8+ T cells and human T cells 38 3.Overexpression of Ets-1 increases IL-2 production 40 4.Ets-1 can be recruited to the proximal promoter of IL-2 41 5.Ets-1 can transactivate IL-2 promoter 42 6.Reduced IL-2-luciferase activity in Ets-1 KO Th1 cells 45 7.Expression of multiple transcription factors in Ets-1 KO Th1 cells 45 8.Suppression of Blimp-1 by Ets-1 in T cells 46 9.Blimp-1 is not the major cause of IL-2 deficiency in Ets-1 KO T cells 47 10.Runx1 and Runx3 suppress Ets-1 induced IL-2 promoter activity 49 11.Functionally synergy between Ets-1 and NFAT in transactivating IL-2 50 12.Ets-1 interacts with Nfatc1 and Nfatc2 in Th1 cells 52 13.Multiple domains of Ets-1 interact with NFAT 52 14.ETS domain of Ets-1 is required for Ets-1/NFAT in transactivating IL-2 promoter 54 15.Recruitment of NFAT was reduced in the absence of Ets-1 in Th1 cells 55 16.Synergistic effect between Ets-1 and Nfat proteins when the EBS was abolished 56 17.Defect in nuclear entry of NFAT in Ets-1 KO Th1 cells 57 18.Calcium dependent signals drive nuclear exit of Ets-1 58 19.mRNA expression of NRON complex components in Ets-1 KO cells 60 20.Ets-1 interacts with NRON complex 63 21.Ets-1 is required for efficient nuclear entry of NFAT 65 Discussion 67 CHARPTER IV. Phenotypic characterization of CD8+ T cells in P054 mice 75 Results 75 1.Phenotypic characterization of CD8+ T cells in P054 mice 75 2.Control of IL-2, granzyme B and IFNgamma expression in CD8+ T cells by Runx3 77 3.Runx3 regulates the expression of Eomesodermin 78 4.Regulation of cytokine productions by Eomes 79 5.Ets-1 drives Eomes promoter 80 Discussion 82 REFERENCES 84 FIGURES AND FIGURE LEGENDS 97 | |
| dc.language.iso | en | |
| dc.subject | 基因調控 | zh_TW |
| dc.subject | 介白素二 | zh_TW |
| dc.subject | Ets-1 | en |
| dc.subject | IL-2 | en |
| dc.subject | NRON | en |
| dc.subject | NFAT | en |
| dc.subject | Blimp-1 | en |
| dc.title | Ets-1在調控介白素二中所扮演之角色 | zh_TW |
| dc.title | The Roles of Ets-1 in IL-2 Regulation | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-1 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 孔祥智(John T. Kung),伍安怡(Betty A. Wu-Hsieh),李建國(Chien-Kuo Lee),徐立中(Li-Chung Hsu) | |
| dc.subject.keyword | 介白素二,基因調控, | zh_TW |
| dc.subject.keyword | Ets-1,IL-2,NRON,NFAT,Blimp-1, | en |
| dc.relation.page | 146 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2013-10-02 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 免疫學研究所 | zh_TW |
| 顯示於系所單位： | 免疫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-102-1.pdf 未授權公開取用 | 4.36 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。